デフォルト表紙
市場調査レポート
商品コード
1593524

細胞分離の市場規模・シェア・成長分析 (製品別、細胞の種類別、細胞供給源別、技術別、用途別、地域別):産業予測 (2024~2031年)

Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 188 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
細胞分離の市場規模・シェア・成長分析 (製品別、細胞の種類別、細胞供給源別、技術別、用途別、地域別):産業予測 (2024~2031年)
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の細胞分離の市場規模は、2022年に42億米ドルと評価され、2023年の47億4,000万米ドルから2031年には124億2,000万米ドルに拡大し、予測期間中 (2024~2031年) に12.80%のCAGRで成長する見通しです。

世界の細胞分離市場は、生物製剤開発、治療用タンパク質合成、内部分析、研究などの用途における重要な役割によって、力強い成長を遂げています。がんやCOVID-19のような慢性疾患の有病率の上昇と費用の増加は、バイオテクノロジーを強化する政府のイニシアチブと相まって、主要な成長決定要因となっています。NanoString Technologies、Levitas Bio、Bionano Genomicsのような企業は、製造プロセスを強化し、製品提供を拡大することで、高度な活用領域のための正確な細胞選択を可能にしています。COVID-19パンデミックは、新しい治療や診断補助の研究をさらに加速させ、2020年8月の米国緊急支出法案のようなイニシアチブは、細胞分離機器の需要を後押ししています。 特殊医薬品とジェネリック医薬品が飛躍的に拡大するにつれて、バイオ医薬品への依存度の上昇が市場を活性化させます。

目次

イントロダクション

  • 分析目的
  • 定義
  • 市場範囲

分析手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場の概要と見通し
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • 技術分析
  • 価格分析
  • バリューチェーン分析
  • 特許分析
  • サプライチェーン分析
  • 規制情勢
  • 顧客と購買基準の分析

細胞分離市場:製品別

  • 市場概要
  • 消耗品
    • 試薬キット・培地血清
    • ビーズ
    • 磁気ビーズ
    • 蛍光ビーズ
    • 使い捨て
  • 装置
    • 遠心分離機
    • 細胞選別機
    • 磁気活性型細胞分離システム
    • 濾過システム

細胞分離市場:細胞の種類別

  • 市場概要
  • ヒト細胞
    • 分化細胞
    • 幹細胞
  • 動物細胞

細胞分離市場:細胞供給源別

  • 市場概要
  • 脂肪組織
  • 骨髄
  • 臍帯血/胚性幹細胞
  • その他の細胞供給源

細胞分離市場:技術別

  • 市場概要
  • 遠心分離ベースの細胞分離
  • 表面マーカーベースの細胞分離
  • 濾過ベースの細胞分離

細胞分離市場:用途別

  • 市場概要
  • 生体分子の分離
  • がん研究
  • 幹細胞研究
  • 組織再生と再生医療
  • 体外診断
  • その他の用途

細胞分離市場:エンドユーザー別

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 病院・診断研究所
  • その他のエンドユーザー

細胞分離市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ (MEA)
    • 湾岸協力会議 (GCC) 諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア (2023年)

主要企業プロファイル

  • Danaher Corporation (米国)
  • Merck KGAA (ドイツ)
  • Thermo Fisher Scientific Inc. (米国)
  • BD (Becton, Dickinson and Company) (米国)
  • Sartorius AG (ドイツ)
  • Agilent Technologies, Inc. (米国)
  • Bio-Rad Laboratories, Inc. (米国)
  • Qiagen (オランダ)
  • F. Hoffmann-La Roche Ltd. (スイス)
  • Revvity (米国)
  • Lonza (スイス)
  • Bio-Techne (米国)
  • Terumo Corporation (日本)
  • Miltenyi Biotec (ドイツ)
  • Takara Bio Inc. (日本)
  • Genscript (中国)
  • Standard Biotools (米国)
  • Alfa Laval (Sweden)
  • Promega Corporation (米国)
  • Cell Signaling Technology, Inc. (米国)
  • Micareo Inc. (米国)
  • Applied Cells Inc. (米国)
  • Stemcell Technologies (カナダ)
  • Creative Bioarray (米国)
  • Proteintech Group, Inc. (米国)
  • Magbio Genomics, Inc. (米国)
  • Akadeum Life Sciences (米国)
  • Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (ドイツ)
  • Invent Biotechnologies, Inc. (米国)
目次
Product Code: SQMIG35H2298

Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).

The global cell isolation market is witnessing robust growth driven by its critical role in applications such as biologics development, therapeutic protein synthesis, internal analysis, and research. Rising prevalence and costs of chronic diseases like cancer and COVID-19, coupled with government initiatives to bolster biotechnology, are key growth determinants. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics are enhancing their manufacturing processes and expanding product offerings, enabling precise cell selection for advanced applications. The COVID-19 pandemic further accelerated research in new treatment and diagnostic aids, with initiatives like the U.S. emergency spending bill of August 2020 boosting demand for cell isolation equipment. Growing reliance on biopharmaceuticals fuels the market as specialty and generic medicines expand exponentially.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Isolation Market Segmental Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Isolation Market

One of the key drivers of the global cell isolation market is the rising prevalence of chronic diseases, particularly cancer. As cancer cases surge globally, there is a growing demand for advanced research and treatment solutions. Cell isolation plays a pivotal role in cancer research by enabling the study of specific cell types, facilitating the development of targeted therapies and personalized medicine. Isolated cells provide critical insights into tumor biology, drug resistance, and immune responses, driving the creation of more effective treatments. Additionally, the increasing adoption of advanced therapies, such as immunotherapy, further boosts the demand for cell isolation techniques. This trend underscores the importance of innovation in the cell isolation market, as research institutes and biotech firms intensify their efforts to combat chronic diseases.

Restraints in the Global Cell Isolation Market

A significant restraint in the global cell isolation market is the high cost of specialized equipment and technologies required for isolating specific cell types. Advanced tools such as flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems are costly, limiting access, particularly for smaller research institutions and laboratories. Additionally, the ongoing expenses related to reagents, as well as the need for highly skilled personnel to operate the equipment, further elevate the financial burden. These factors may restrict the widespread adoption and utilization of advanced cell isolation techniques, particularly in regions with limited financial resources or budget constraints.

Market Trends of the Global Cell Isolation Market

A key trend shaping the global cell isolation market is the growing adoption of microfluidics technology. This innovative approach utilizes small quantities of fluids through microchannels to precisely separate cells based on characteristics such as length, shape, and other biological properties. Microfluidics is gaining significant traction for its ability to efficiently isolate rare cells, such as circulating tumor cells (CTCs) and stem cells, from complex biological samples. Its enhanced precision and performance, coupled with cost-effective processing that minimizes reagent usage, make it a highly attractive solution for both research and medical applications. As a result, microfluidics is poised to revolutionize cell isolation, offering improved accuracy and efficiency in diverse clinical and research settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Patent Analysis
  • Supply Chain Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Cell Isolation Market by Product

  • Market Overview
  • Consumables
    • Reagents, Kits, Media, And Sera
    • Beads
    • Magnetic Beads
    • Fluorescent Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Cell Sorters
    • Magnetic-Activated Cell Separator Systems
    • Filtration Systems

Cell Isolation Market by Cell Type

  • Market Overview
  • Human Cells
    • Differentiated Cells
    • Stem Cells
  • Animal Cells

Cell Isolation Market by Cell Source

  • Market Overview
  • Adipose Tissue
  • Bone Marrow
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

Cell Isolation Market by Technique

  • Market Overview
  • Centrifugation-Based Cell Isolation
  • Surface Marker-Based Cell Isolation
  • Filtration-Based Cell Isolation

Cell Isolation Market by Application

  • Market Overview
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration & Regenerative Medicine
  • In Vitro Diagnostics
  • Other Applications

Cell Isolation Market by End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories
  • Other End Users

Cell Isolation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGAA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genscript (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Standard Biotools (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alfa Laval (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Signaling Technology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micareo Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cells Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Technologies (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Bioarray (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteintech Group, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Magbio Genomics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Akadeum Life Sciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invent Biotechnologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments